Investigating the Role of Microcirculatory Dysfunction in Sepsis-Induced Organ Failure and Its Modulation by Endothelial Glycocalyx Preservation Therapies

Project Abstract

Microcirculatory dysfunction is a pivotal yet underappreciated driver of organ failure in sepsis, arising from heterogeneous perfusion, capillary leak, leukocyte-endothelial interactions, and disruption of the endothelial glycocalyx. This study investigates the mechanistic linkages between microvascular derangements and sepsis-induced organ dysfunction and evaluates the therapeutic potential of preserving the endothelial glycocalyx to restore microcirculatory flow and improve clinical outcomes. A multifaceted approach combines translational animal models of polymicrobial sepsis with ex vivo microvascular imaging and human patient data to delineate how glycocalyx degradation contributes to capillary rarefaction, impaired rheology, and trans-endothelial albumin extravasation. Advanced intravital microscopy, sidestream dark-field imaging, and hyperspectral imaging quantify capillary density, perfused vessel fraction, red blood cell velocity, and tissue oxygenation across vital organs, alongside circulating biomarkers of glycocalyx shedding (syndecan-1, heparan sulfate), endotheliopathy, and systemic inflammatory response. Parallel in vitro studies on cultured microvascular endothelial cells expose differential responses to septic mediators, assessing glycocalyx thickness via lectin binding assays and the activity of sheddases such as metalloproteinases and heparanase, with downstream effects on barrier function, nitric oxide signaling, and leukocyte adhesion. The therapeutic arm examines pharmacologic strategies aimed at glycocalyx preservation, including sulodex, hydrocortisone with adjunctive agents, and novel glycocalyx-stabilizing compounds, evaluating their impact on microvascular perfusion, endothelial permeability, and organ function in septic models. Clinically, the study analyzes sequelae of microcirculatory impairment in septic patients, correlating glycocalyx integrity with organ dysfunction scores, lactate clearance, and 28-day mortality, while exploring timing and dosing windows for intervention. Computational modeling integrates hemodynamic data with endothelial surface layer dynamics to simulate microcirculatory flow under septic conditions and predict responses to glycocalyx-targeted therapy. The anticipated outcomes include establishing a causal relationship between glycocalyx degradation and microcirculatory collapse, identifying reliable biomarkers for early detection of microvascular dysfunction, and defining actionable therapeutic regimens that preserve glycocalyx structure, reduce vascular leak, and enhance tissue oxygen delivery. By integrating mechanistic insights with translational endpoints, the research aims to inform precision medicine strategies in sepsis management, reduce progression to multi-organ failure, and improve survival. Potential challenges such as interindividual variability, the temporal evolution of glycocalyx damage, and the balance between anti-inflammatory effects and host defense are addressed through stratified analyses and rigorous cross-validation across models. This work aspires to shift the paradigm from solely hemodynamic stabilization to comprehensive microcirculatory restoration as a cornerstone of sepsis therapy.

Project Overview

What This Project Is About

---

The project looks at how sepsis, a serious body-wide infection, can disrupt the tiny blood vessels (microcirculation) and how this disruption leads to organ problems. It also explores strategies to protect or restore the lining that coats blood vessels (the endothelial glycocalyx) to reduce damage.

---

---

The Problem It Addresses

---

In sepsis, poor blood flow in small vessels can deprive organs like the kidneys and lungs of oxygen, causing organ failure. Not all patients respond to treatments in the same way, and the role of the vascular surface layer (glycocalyx) is not fully understood. The project seeks to clarify these links to improve outcomes.

---

---

Objectives of the Project

---

1. Explain how microcirculatory dysfunction contributes to organ injury in sepsis.
2. Describe what the endothelial glycocalyx is and why preserving it might help.
3. Identify potential therapies or strategies that protect the glycocalyx.
4. Assess how findings could guide better clinical management of sepsis.

---

---

What You Will Do Step by Step

---

1. Review basic physiology of microcirculation and glycocalyx in simple terms.
2. Summarize current research on sepsis-related microvascular changes.
3. Explain conceptually how preservation therapies work.
4. Outline a hypothetical study design to test these ideas in a lab or data analysis setting.
5. Describe data types you would collect and how you would interpret them.

---

---

---

---

Expected Outcome

A clear, accessible understanding of how microcirculation and the glycocalyx influence sepsis outcomes, plus a concise plan for studying or testing preservation strategies that could inform future research or clinical guidelines.